Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit - Wikidata - awgldk - TriplyDB

Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit

Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit

http://www.wikidata.org/entity/Q33698152

about

Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?A tonsillar PolyICLC/AT-2 SIV therapeutic vaccine maintains low viremia following antiretroviral therapy cessation Willingness to participate in HIV therapeutic vaccine trials among HIV-infected patients on ART in China Intramuscular delivery of heterodimeric IL-15 DNA in macaques produces systemic levels of bioactive cytokine inducing proliferation of NK and T cells The influence of delivery vectors on HIV vaccine efficacy Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizations Regulatory T cells in HIV immunotherapy Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaques SIV antigen immunization induces transient antigen-specific T cell responses and selectively activates viral replication in draining lymph nodes in retroviral suppressed rhesus macaques HIV DNA Vaccine: Stepwise Improvements Make a Difference.IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques Comparison of DNA vaccines producing HIV-1 Gag and LAMP/Gag chimera in rhesus macaques reveals antigen-specific T-cell responses with distinct phenotypes.DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV.Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancer.Functions of IL-15 in anti-viral immunity: multiplicity and variety.Immunotherapeutic applications of IL-15.DNA prime/protein boost vaccination elicits robust humoral response in rhesus macaques using oligomeric simian immunodeficiency virus envelope and Advax delta inulin adjuvant.ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment.Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during simian-human immunodeficiency virus infection.Control of Heterologous Simian Immunodeficiency Virus SIV Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques

P2860

Q26865388-1748E906-8592-4C6D-BDEB-322E4F02B58A Q27319650-424781F2-9E33-4999-927D-B122BC8D3E1F Q28544731-ED350DBA-BEE5-4CE1-ABAC-179DFDD909C3 Q28652428-82698696-CB2A-43C4-BBFC-E7E9D9C3E671 Q34077543-A15E0081-BFFE-4A03-AC5D-F88AB84FADDF Q34593874-3A7A2212-2E14-4A4E-B238-D6753BA89E98 Q34725547-640D6E28-7A0B-4DD9-9705-9E7343565A29 Q35046349-1773F851-6A80-4CDC-80D6-B7131BF94C13 Q35143735-9FD7000F-DFCF-4B9D-8E05-9E16C9B9E06D Q35826742-68912288-2709-4EFD-8309-9F0E95FB841B Q36694836-916B25E2-F4C3-43FC-952D-E294BD2C4E88 Q37344832-42C74ABB-D139-40ED-A002-6C8B2FBAF76E Q37395174-7B381B4F-6D06-4379-B23F-8A7D9ED9EF98 Q37685855-44AAEA84-3CA0-4052-A591-908D116886BA Q38019210-A81B702F-A442-4F50-9A76-E4BDC41C29F5 Q38050510-E611DB94-DFF8-41AB-BDDD-49FE2AE44095 Q40101584-20BC6132-3CBC-4EBD-8F27-2F56CE15670A Q47585968-A508994B-FB8F-4D7E-BA57-6B1567C6F367 Q52592228-BBC630AF-B57A-4FF7-84EA-6D1E4D03219C Q56517308-99D0F1AF-397A-4647-9A50-48C11FCB4921

P2860

Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit

http://www.wikidata.org/entity/Q33698152

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Repeated DNA therapeutic vacci ...... additional virological benefit

@ast

Repeated DNA therapeutic vacci ...... additional virological benefit

@en

type

label

Repeated DNA therapeutic vacci ...... additional virological benefit

@ast

Repeated DNA therapeutic vacci ...... additional virological benefit

@en

prefLabel

Repeated DNA therapeutic vacci ...... additional virological benefit

@ast

Repeated DNA therapeutic vacci ...... additional virological benefit

@en

P1433

Q33698152-00F2990D-ADFA-4A6D-91E8-5703249D0352

P1476

Q33698152-98531760-577A-4BC8-A912-1C92AB389C43

P2093

Q33698152-0CB98DC9-29D2-4C7C-AB5F-F805602592AD

Q33698152-476A46E3-2ED6-4FEB-98CD-A0035F6C44D9

Q33698152-49C05732-36B6-4DD5-AF36-871DDEF9C4E3

Q33698152-4BA717ED-44E5-421E-89E1-55B0CD99080D

Q33698152-71139858-8F4E-4AF1-B413-6869B108C8D5

Q33698152-7F739DC1-2439-425A-9DB3-40159EC6DC91

Q33698152-80A93528-E0C1-4ADF-91E4-80703FFCBDFB

Q33698152-95A178E2-258F-4CAA-9DCB-01CCD6E28410

Q33698152-A9DF6E47-B673-46DB-A93B-286EDE2EAA94

Q33698152-BADA5FC4-B795-4FA8-A34D-A82DF4D3FC88

P2860

Q33698152-053574B1-11E8-474C-AAFC-2601AB22E632

Q33698152-074163A1-D65A-41DC-82D9-F63BD7477B6C

Q33698152-0F7586D2-94E6-466A-A5DB-FF45FF562315

Q33698152-12BA67A5-68F1-4BA4-A1E6-E1370F95F53D

Q33698152-18F3F9B2-815C-4888-BF0A-7B80DAF906E7

Q33698152-1A103991-F0FA-470B-A76B-65E19D3E7FB1

Q33698152-1A4EB0DB-86D7-4B63-A730-075D0238A7AF

Q33698152-1AFA2D85-DA2C-4636-B7C5-B2A66BA8FE75

Q33698152-1D97DDA4-BBDC-4F46-80B8-E4FD3C110FFB

Q33698152-1DC40476-0BFB-44D1-9E77-22ED753D39EE

P304

Q33698152-4EA1D7FF-B48F-45CD-96B8-E75CCD040A00

P31

Q33698152-E4A246C5-A486-4D83-9C3B-9FB935846AEF

P356

Q33698152-C923113E-7AB5-49F1-A3C7-067877148E83

P407

Q33698152-809BDC9B-C8C7-4453-B4F7-14B4559119A6

P433

Q33698152-D91D2940-A3C6-4A64-AC63-82697996FB49

P478

Q33698152-CC1EAB66-ADCA-42FA-8356-F463DC481CCE

P577

Q33698152-37BD68FA-86CC-44F2-BC5B-56CCAD1DA37A

P5875

Q33698152-FE1F4C7E-6E3A-4C18-B3E8-25CF5E9814F0

P698

Q33698152-5B315B54-F043-47E6-82F1-4C67A1799386

P921

Q33698152-530ABE03-E64C-4EB2-92EA-09994A5391C8

P932

Q33698152-3A317FE3-A07B-46C4-814E-E1773B0CB3A0

P356

J.VACCINE.2009.10.099

P1433

P1476

Repeated DNA therapeutic vacci ...... additional virological benefit

@en

P2093

Agneta von Gegerfelt

http://www.w3.org/2001/XMLSchema#string

Amir S Khan

http://www.w3.org/2001/XMLSchema#string

Antonio Valentin

http://www.w3.org/2001/XMLSchema#string

Barbara K Felber

http://www.w3.org/2001/XMLSchema#string

Candido Alicea

http://www.w3.org/2001/XMLSchema#string

Cristina Bergamaschi

http://www.w3.org/2001/XMLSchema#string

George N Pavlakis

http://www.w3.org/2001/XMLSchema#string

Georgios Miteloudis

http://www.w3.org/2001/XMLSchema#string

Margherita Rosati

http://www.w3.org/2001/XMLSchema#string

Rashmi Jalah

http://www.w3.org/2001/XMLSchema#string

P2860

Post-exposure prophylaxis for SIV revisited: animal model for HIV prevention

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection

Control of viremia and prevention of AIDS following immunotherapy of SIV-infected macaques with peptide-pulsed blood

beta-catenin is a target for the ubiquitin-proteasome pathway

A review of vaccine research and development: the human immunodeficiency virus (HIV).

DNA vaccines for HIV: challenges and opportunities.

DNA encoding an HIV-1 Gag/human lysosome-associated membrane protein-1 chimera elicits a broad cellular and humoral immune response in Rhesus macaques.

Immunological responses and long-term treatment interruption after human immunodeficiency virus type 1 (HIV-1) lipopeptide immunization of HIV-1-infected patients: the LIPTHERA study.

Early short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn Rhesus macaques.

Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment

P304

1962-1974

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2009.10.099

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41620855

http://www.w3.org/2001/XMLSchema#string

P698

20188252

http://www.w3.org/2001/XMLSchema#string

P921

P932

2830913

http://www.w3.org/2001/XMLSchema#string